Registered Attendees

Registered Attendees

Print This Page

Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online before the meeting...these abstracts will be available in the Abstract Book at the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Close Window
Fairmont Hotel Vancouver Floorplan

Fairmont Hotel Vancouver Floorplan

Print This Page



Close Window
NOTES:
This meeting occurs in 2015.
This meeting will be conducted in English.

All programs are subject to change. Check this site for updates.


Download Flyer

Twitter hashtag for this meeting: #Kstumormet

Integrating Metabolism and Tumor Biology (J1)

joint with the meeting on PI 3-Kinase Signaling Pathways in Disease (J2)

Scientific Organizers: Ralph J. DeBerardinis, Robert T. Abraham and Eyal Gottlieb


January 13—18, 2015

Fairmont Hotel Vancouver, Vancouver, British Columbia, Canada


Sponsored by Astellas Pharma Inc., Bayer HealthCare Pharmaceuticals, Cell Signaling Technology, Inc., ImmunoGen, Inc., Pfizer Inc. and Takeda Pharmaceutical Company


Abstract submission is closed. Registered attendees can bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested. Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

DEADLINES:
Scholarship Deadline: Sep 24, 2014 [details]
Discounted Abstract Deadline: Sep 24, 2014 [details]
Abstract Deadline: Oct 16, 2014 [details]
Discounted Registration Deadline: Nov 13, 2014 [details]

Register Yourself Deadlines and Fees
Deadlines and Fees for 2015-J1 ''Integrating Metabolism and Tumor Biology''
Print This Page

Rates and Deadlines listed below are for the 2015-J1 "Integrating Metabolism and Tumor Biology" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On September 24, 2014 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After September 24, 2014 until November 13, 2014 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
September 24, 2014 n/a
Discounted NON-STUDENT Registration
More details
Before and On November 13, 2014 845.00 USD
(includes 150.00 discount)
Regular NON-STUDENT Registration
More details
After November 13, 2014 995.00 USD
Discounted STUDENT Registration
More details
Before and On November 13, 2014 620.00 USD
(includes 150.00 discount)
Regular STUDENT Registration
More details
After November 13, 2014 770.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will    accept no liability for money loss through bank charges, transfers or currency fluctuations.

Close Window



About Discounted Abstract Deadline
About Global Health Travel Award Deadline
About Scholarship Deadline
About Abstract Deadline
About Discounted Registration Deadline
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


TUESDAY, JANUARY 13

16:00—20:00
Arrival and Registration

18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.


WEDNESDAY, JANUARY 14

07:00—08:00
Breakfast

08:00—09:00
Keynote Address (Joint)
Registered attendees can view abstracts starting on 12/13/2014

Lewis C. Cantley, Weill Cornell Medical College, USA
Phosphoinositide Kinases and Cancer Metabolism

09:00—11:45
Oncogenic Control of Metabolism (Joint)
Registered attendees can view abstracts starting on 12/13/2014

* Ralph J. DeBerardinis, University of Texas Southwestern Medical Center, USA

Ronald A. DePinho, University of Texas MD Anderson Cancer Center, USA
KRAS in Cancer Cell Metabolism and Tumor Maintenance

Emilio Hirsch, Fondazione per la Ricerca Biomedica – ONLUS, Italy
PI3K Class II gamma Is a Rab5 Effector Selectively Controlling Endosomal Akt2 Activation Downstream Insulin Signaling

John Blenis, Weill Cornell Medical College, USA
mTOR Control of Glutamine Metabolism

David M. Sabatini, Whitehead Institute for Biomedical Research, USA
mTOR and the Cell Biology of Nutrient Sensing

Wei-Xing Zong, Stony Brook University, USA
Short Talk: Myc Induces Expression of Glutamine Synthetase through Thymine DNA Glycosylase-Mediated Promoter Demethylation

09:40—10:00
Coffee Break

11:45—13:00
Poster Setup

13:00—22:00
Poster Viewing

11:45—14:30
On Own for Lunch

16:30—17:00
Coffee Available

17:00—19:00
Metabolic Perturbations that Drive Malignancy
Registered attendees can view abstracts starting on 12/13/2014

* Eyal Gottlieb, Cancer Research UK, Beatson Institute, UK

Matthew G. Vander Heiden, Massachusetts Institute of Technology, USA
Role of Glycolytic Regulation in Tumor Biology

Bo Li, University of Pennsylvania Perelman School of Medicine, USA
Short Talk: Fructose-1,6-Bisphosphatase Opposes Renal Carcinoma Progression

Julie-Aurore Losman†, Dana-Farber Cancer Institute, USA
2-Hydroxyglutarate Induces a Reversible State of Malignant Transformation

Binhua (Peter) P. Zhou, University of Kentucky College of Medicine, USA
Metabolic Facilitators of the Epithelial-Mesenchymal Transition

17:00—19:15
PI3K Effectors
Registered attendees can view abstracts starting on 12/13/2014
Proteins that Bind PI3K Lipid Products: Function in Cancer and Immune Disease.

* Roger L. Williams, Medical Research Council, UK

Alex Toker, Beth Israel Deaconess Medical Center, USA
PI 3-Kinase and Akt at the Interface of Signaling and Metabolism

Yoshinori Fukui, Medical Institute of Bioregulation, Kyushu University, Japan
Critical Roles of DOCK Family Proteins in Migration and Activation of Leukocytes

Aaron J. Marshall, University of Manitoba, Canada
Short Talk: Phosphatidylinositol 3,4 Bisphosphate and its Binding Protein Lammellipodin Are Required for Directional Migration of Malignant B Cells

Sonja Vermeren, University of Edinburgh, UK
PI3K Regulates Integrin-Dependent Processes in the Neutrophil by Signaling through ARAP3

Ming O. Li, Memorial Sloan-Kettering Cancer Center, USA
Short Talk: Sestrins Function as Guanine Nucleotide Dissociation Inhibitors for Rag GTPases to Control mTORC1 Signaling

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 1


THURSDAY, JANUARY 15

07:00—08:00
Breakfast

08:00—11:15
Mitochondrial Metabolism and Cancer
Registered attendees can view abstracts starting on 12/13/2014

* Marcia C. Haigis, Harvard Medical School, USA

Ralph J. DeBerardinis, University of Texas Southwestern Medical Center, USA
Conventional and Unconventional Roles of Mitochondrial Enzymes in Tumor Cell Metabolism

Paul Hwang, NHLBI, National Institutes of Health, USA
Role of TP53 in Regulating Mitochondrial Metabolism

John C. Schell, University of Utah, USA
Short Talk: The Mitochondrial Pyruvate Carrier Enforces the Warburg Effect and Is Important for Cancer-Initiating Cell Maintenance

Pierre Sonveaux, University of Louvain, Medical School, Belgium
Short Talk: A Mitochondrial Switch Promotes Tumor Metastasis

Navdeep S. Chandel, Northwestern University, USA
Mitochondrial Metabolism Regulates Cell Proliferation and Epigenetics

Andre Catic, Baylor College of Medicine, USA
Short Talk: Nuclear Proteolysis as a Metabolic Regulator

Roger Geiger, Institute for Research in Biomedicine, Switzerland
Short Talk: Influence of L-Arginine on Metabolic Networks and the Lifespan of Activated T Cells

08:00—11:15
PI3K/Akt/mTOR in Immune Function, Inflammation
Registered attendees can view abstracts starting on 12/13/2014

* Bart Vanhaesebroeck, University College London, Cancer Institute, UK

Phillip T. Hawkins, Babraham Institute, UK
PI3K Signaling in Neutrophils

Klaus Okkenhaug, Babraham Institute, UK
PI3Kdelta in Immunity, Infection and Cancer

Judith A. Varner, University of California, San Diego, USA
Short Talk: Targeting PI3Kgamma Activates Anti-Tumor Immune Responses and Promotes Cancer Survival

David A. Fruman, University of California, Irvine, USA
Insights Concerning the Selective Action of Rapamycin in Lymphocytes

Robert C. Rickert, Sanford-Burnham Medical Research Institute, USA
The PI3K Pathway in B Cell Metabolism

Yina H. Huang, Dartmouth College, USA
Short Talk: Calmodulin and PI(3,4,5)P3 Cooperatively Bind to the Itk Pleckstrin Homology Domain to Promote Efficient Calcium Signaling and IL-17A Production in T Cells

09:20—09:40
Coffee Break

11:15—13:00
Poster Setup

13:00—22:00
Poster Viewing

11:15—14:30
On Own for Lunch

14:30—16:30
Workshop 1: Novel Targets and Pathways

* Costas A. Lyssiotis, Weill Cornell Medical College, USA

Serkan Kir, Dana-Farber Cancer Institute, USA
Tumor-Derived PTH-Related Protein Triggers Adipose Tissue Browning and Cancer Cachexia

Saverio Tardito, Beatson Institute for Cancer Research, Scotland
De novo Purine Biosynthesis Dictates Glutamine Dependency of Glioblastoma Cells

Jiyeon Kim, University of Texas Southwestern Medical Center, USA
Unconventional Pathways of Nitrogen Metabolism in Lung Cancer

Jonathan L. Coloff, Harvard Medical School, USA
Regulation of Glutamine Metabolism in Epithelial Cell Proliferation and Quiescence

Atsuo T. Sasaki, University of Cincinnati, USA
SSK1, a Novel GTP-Dependent Kinase, Detects GTP Levels and Regulates Tumorigenesis

Etienne Audet-Walsh, McGill University, Canada
The Estrogen-Related Receptor Gamma Is a Key Determinant of Androgens-Mediated Energy Reprogramming of Prostate Cancer Cells

Zhimin Lu, University of Texas MD Anderson Cancer Center, USA
Phosphoglycerate Kinase 1 Coordinates Glycolysis and TCA Cycle in Tumorigenesis

16:30—17:00
Coffee Available

17:00—19:00
Model Organisms as Tools to Understand Metabolism, Growth and Cancer
Registered attendees can view abstracts starting on 12/13/2014

* David M. Sabatini, Whitehead Institute for Biomedical Research, USA

Benjamin Tu, University of Texas Southwestern Medical Center, USA
What is TORC1 doing to Cellular Metabolism?

Alex Gould, MRC National Institute for Medical Research, UK
Protecting Neural Stem Cells from Starvation and Hypoxia in Drosophila

Gabriela David, Baylor College of Medicine, USA
Short Talk: Wacky Is a Novel Regulator of mTOR Signaling

Leonard I. Zon, HHMI/Children's Hospital Boston, USA
The Role of Nucleotide Deficiency in the Transcriptional Regulation of Neural Crest Differentiation and Melanoma

17:00—19:15
PI3K in Cancer
Registered attendees can view abstracts starting on 12/13/2014

Lori Friedman, Genentech, Inc., USA
Sensitivity and Resistance to PI3K Pathway Inhibitors

Vuk Stambolic, Ontario Cancer Institute/University Health Network, Canada
Nuclear PTEN Function in Tumor Suppression

* Jean J. Zhao, Dana-Farber Cancer Institute, USA
Targeting PI3K Isoforms in Cancer: Mechanistic and Therapeutic Insights from Genetic Mouse Models

Inma M. Berenjeno, University College London, Cancer Institute, UK
Short Talk: Induction of Chromosomal Instability by Oncogenic PIK3CA and its Possible Implications

Miguel Murillo, Institute of Cancer Research, UK
Short Talk: Disruption of the Interaction of RAS with PI3K p110alpha Induces Regression of EGFR-Driven Lung Tumors

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 2


FRIDAY, JANUARY 16

07:00—08:00
Breakfast

07:30—08:00
Poster Setup

08:00—17:00
Poster Viewing

08:00—11:15
Targeting Cancer Cell Metabolism
Registered attendees can view abstracts starting on 12/13/2014

* Michael Pollak, McGill University and Lady Davis Research Institute, Canada

Robert J. Gillies, H. Lee Moffitt Cancer Center and Research Institute, USA
Buffer Therapy

Deepak Nagrath, Rice University, USA
Short Talk: Deconstructing Glutamine’s Role in Regulating Aggressiveness, Drug Sensitivity in Ovarian Cancer Cells

Katharine Yen, Agios Pharmaceuticals, USA
Targeting Mutant IDH in Cancer

Reuben J. Shaw, The Salk Institute, USA
The LKB1 - AMPK Tumor Suppressor Pathway: Metabolic Reprogramming and Therapeutic Targeting

Russell G. Jones, McGill University, Canada
Short Talk: The Oncogenic MicroRNA miR-17-92 Regulates Tumor Metabolism through Suppression of LKB1-AMPK Signaling

Gina DeNicola, Weill Cornell Medical Center, USA
Short Talk: NRF2 Regulates Serine Biosynthesis in Non-Small Cell Lung Cancer

Dohoon Kim, Whitehead Institute for Biomedical Research, USA
Short Talk: SHMT2 Drives Glioma Cell Survival in the Tumor Microenvironment but Imposes a Dependence on Glycine Clearance

08:00—11:00
PI3K/Akt/mTOR Clinical Translational - Oncology
Registered attendees can view abstracts starting on 12/13/2014

* Lori Friedman, Genentech, Inc., USA

José Baselga, Memorial Sloan-Kettering Cancer Center, USA
PI3K and mTOR Inhibitors in Breast Cancer

Mika Derynck, Genentech, Inc., USA
Clinical Development of PI3K Inhibitors at Genentech: Is there Clinical Proof of Concept with this Class of Agents in Solid Tumors?

Jeffrey Kutok, Infinity Pharmaceuticals, Inc, USA
Short Talk: Duvelisib Inhibits Malignant B-Cell Proliferation and Disrupts Signaling from the Tumor Microenvironment through Mechanisms that are Dependent on PI3K-delta and PI3K-gamma

Arthur L. Shaffer III, NCI, National Institutes of Health, USA
Short Talk: Mechanisms of Ibrutinib Resistance in the Aggressive, ABC-subtype of Diffuse Large B Cell Lymphoma: PI3K and Pathways to new Therapeutic Options

Timothy Richard Wilson, Genentech, Inc., USA
Short Talk: Biomarker Analysis from a Phase I Dose Escalation Study of Taselisib (GDC-0032), a beta Isoform-Sparing PI3K Inhibitor

Michel Maira, Novartis Institute for BioMedical Research, Switzerland
PI3K Inhibitors for Cancer Treatment: Translational Research and Beyond

09:20—09:40
Coffee Break

11:15—12:00
Lunch

12:00—14:30
Poster Session 3

14:30—16:30
Workshop 2: Strategies for Discovery of Therapeutic Targets and Metabolism-Targeted Drugs

* Arkaitz Carracedo, Center for Cooperative Research in Biosciences, Spain

Michael E. Pacold, Whitehead Institute for Biomedical Research, USA
Selective Toxicity of a 3-Phosphoglycerate Dehydrogenase Inhibitor towards PHGDH-Dependent Cells in vitro and in vivo

Jing Chen, Winship Cancer Institute, Emory University, USA
Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling

Robert U. Svensson, The Salk Institute for Biological Studies, USA
Acetyl-CoA Carboxylase Inhibition by ND646 Reduces Fatty Acid Synthesis and Inhibits Tumor Growth of Human Non-Small Cell Lung Cancer Cells

Hector C. Keun, Imperial College London, UK
MCT1-Dependent Lactate Utilisation Is an Adaptive Response that Maintains Tumor Cell Proliferation, Lipogenesis and Redox Balance under Glucose Deprivation

Ayelet Erez, Weizmann Institute of Science, Israel
Aspartate Metabolism Links the Urea Cycle with Nucleic Acid Synthesis in Cancerous Proliferation

Chiara Gorrini, Campbell Family Institute for Breast Cancer Research, Canada
BRCA1-Associated Tumorigenesis: A Matter of ROS Balance

14:30—16:30
Workshop 1: PI3K Structure and Enzymology

* Jonathan M. Backer, Albert Einstein College of Medicine, USA

Takehiko Sasaki, Akita University School of Medicine, Japan
A New Methodology for Studying Phosphoinositide Signaling at the Molecular Species Level

John E. Burke, University of Victoria, Canada
Deciphering the Dynamic Regulation of Phosphoinositide Kinases on Membrane Surfaces

Natasha S. Clayton, University of Cambridge, UK
Regulation of PI3K Activity by Activated Cdc42-Associated Kinase (ACK)

Christl Gaubitz, University of Geneva, Switzerland
Structural basis of the Rapamycin Insensitivity of Target of Rapamycin Complex 2

Goran Stjepanovic, University of California, Berkeley, USA
Architecture and Dynamics of the Autophagic Phosphatidylinositol 3-Kinase Complex

Oscar Vadas, University of Geneva, Switzerland
Regulation of PI3Kgamma Downstream of GPCRs

16:30—17:00
Coffee Available

17:00—19:30
Metabolite Control of Gene Expression and Protein Function
Registered attendees can view abstracts starting on 12/13/2014

* Matthew D. Hirschey, Duke University, USA

Craig B. Thompson, Memorial Sloan-Kettering Cancer Center, USA
Metabolic Control of Epigenetics in Cancer

Christine A. Parachoniak, Massachusetts General Hospital Cancer Center, USA
Short Talk: Mutant IDH Blocks Murine Primary Liver Progenitor Cell Differentiation to Drive Liver Cancer Pathogenesis

Eric M. Verdin, University of California, San Francisco, USA
Mitochondrial Protein Acylation and the Sirtuins

Marcia C. Haigis, Harvard Medical School, USA
Post-Translational Modifications and Control of Mitochondrial Metabolism

Poul H. B. Sorensen, University of British Columbia, Canada
The eEF2K Translation Factor and Metabolic Reprogramming in Tumor Cells

17:00—19:15
PI3K/Akt/mTOR Clinical Translational - Inflammation
Registered attendees can view abstracts starting on 12/13/2014

* David A. Fruman, University of California, Irvine, USA

Stephen Shuttleworth, Karus Therapeutics Ltd., UK
Design and Development of New Class of PI3K-p110beta/delta Inhibitors for the Treatment of Immune-Inflammatory Disease

Augustin Amour, GlaxoSmithKline, UK
The Development of a Promising Inhaled PI3Kdelta Inhibitor for the Treatment of Respiratory Indications

Alison Mary Condliffe, University of Cambridge, UK
Activated PI3 Kinase Delta Syndrome (APDS): A Novel Combined Immunodeficiency Disorder

Carrie L. Lucas, NIAID, National Institutes of Health, USA
Short Talk: Lymphoproliferation and CD8 T Cell Senescence in Primary Human Immunodeficiencies caused by Gene Mutations that Activate PI3K Signaling

Yan-xia Ye, Peking Union Medical College Hospital, China
Short Talk: Defective PTEN Regulation and Function Contributes to B Cell Hyper-Responsiveness in Systemic Lupus Erythematosus

19:30—
On Own for Dinner


SATURDAY, JANUARY 17

07:00—08:00
Breakfast

08:00—11:00
Metabolic Consequences of Cell Stress
Registered attendees can view abstracts starting on 12/13/2014

* Robert T. Abraham, Pfizer Worldwide Research and Development, USA

Eileen P. White, Rutgers University, USA
Autophagy, Metabolism and Cancer

Eyal Gottlieb, Cancer Research UK, Beatson Institute, UK
Pyruvate Carboxylation Is Required for Growth of Succinate Dehydrogenase-Deficient Cells

Karen H. Vousden, Beatson Institute for Cancer Research, UK
A Role for p53 in the Regulation of Metabolism

Kun-Liang Guan, University of California, San Diego, USA
The Hippo-YAP Pathway in Organ Size Control and Tumorigenesis

Andrew M. Intlekofer, Memorial Sloan Kettering Cancer Center, USA
Short Talk: L-2-Hydroxyglutarate Production in Response to Hypoxic Stress

08:00—11:15
Class II/III PI3K, Trafficking
Registered attendees can view abstracts starting on 12/13/2014
Linking Vps34 Regulation of Trafficking with Other Sessions - Autophagy, Metabolism.

* Phillip T. Hawkins, Babraham Institute, UK

Bart Vanhaesebroeck, University College London, Cancer Institute, UK
New Physiological Roles of PI3K Isoforms

Volker Haucke, Leibniz Institut für Molekulare Pharmakologie, Germany
Spatiotemporal control of endocytosis and endosomal membrane traffic by PI 3-phosphates

Nadia L. Jaber, Stony Brook University, USA
Short Talk: Vps34 Controls Rab7 to Regulate Endocytic Trafficking

Sharon A. Tooze, London Research Institute, UK
The Role of PI3P and WIPI2 in Autophagy

Gilbert Di Paolo, Columbia University Medical Center, USA
Dysregulation of Class III PI3K/Vps34 Signaling in Neurons Recapitulates Key Features of Alzheimer's Disease

Svetlana A. Fayngerts, University of Pennsylvania, USA
Short Talk: Of Cell Life and Death: The Phosphoinositide Transfer Domain of the TNFAIP8 Family

09:20—09:40
Coffee Break

11:00—14:30
On Own for Lunch

14:30—16:30
Joint Workshop: Autophagy and Regulation of Anabolic/Catabolic Balance (Joint)

* Leon O. Murphy, Novartis, USA

* Daniel Murphy, University of Glasgow, UK

Rushika M. Perera, Massachusetts General Hospital, USA
Transcriptional Control of the Autophagy-Lysosome System Drives Amino Acid Metabolism in Pancreatic Cancer

Assia Shisheva, Wayne State University School of Medicine, USA
Class III PI 3-Kinase Is the Main Source of PtdIns3P Substrate and Membrane Recruitment Signal for PIKfyve Constitutive Function in Endomembrane Homeostasis

Aimee L. Edinger, University of California, Irvine, USA
Sphingolipid Drugs that Starve Cancer Cells from Inside and Out

Masayuki Noguchi, Hokkaido University, Institute for Genetic Medicine, Japan
The Links between AKT and Two Intracellular Proteolytic Cascades: Ubiquitination and Autophagy

Julien Planchais, Institut Cochin INSERM U1016 CNRS UMR8104 Université Paris Descartes, France
The Glucose-Responsive Transcription Factor ChREBP Enhances Glucose-Dependent Anabolic Biosynthesis and Hepatocyte Proliferation in a PI3K/Akt Dependent Manner

Michael Pollak, McGill University and Lady Davis Research Institute, Canada
Serine Deprivation Enhances Anti-Neoplastic Activity of Biguanides

Biplab Dasgupta, Cincinnati Children's Hospital, USA
AMP Kinase: Evolving Lessons about its Context-Dependent Opposite Roles in Cancer

16:30—17:00
Coffee Available

17:00—18:45
Influence of the Metabolic Environment on Cancer Development and Tumor Growth
Registered attendees can view abstracts starting on 12/13/2014

* Matthew G. Vander Heiden, Massachusetts Institute of Technology, USA

Dafna Bar-Sagi, New York University School of Medicine, USA
Oncogenic Ras-Mediated Metabolic Adaptation

Philipp E. Scherer, University of Texas Southwestern Medical Center, USA
Adipokines and Tumor Progression

Robert T. Abraham, Pfizer Worldwide Research and Development, USA
Glutamine Deprivation Stimulates a Stress-Response Network in Cancer Cells

17:00—18:45
PI3K Structure and Regulation
Registered attendees can view abstracts starting on 12/13/2014
Insights into Structure of PI3K Enzymes, Inhibitor Binding, and Other Modes of Regulation.

* John E. Burke, University of Victoria, Canada

Roger L. Williams, Medical Research Council, UK
Structural Insights into Vps34 Regulation

Leon O. Murphy, Novartis, USA
Generation of Selective VPS34 Inhibitors to Probe the Autophagy Pathway

Jonathan M. Backer, Albert Einstein College of Medicine, USA
The Complex Functions of p110beta: A Critical Integrator of Signals from GPCRs and Small GTPases.

18:45—19:15
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 12/13/2014

18:45—19:15
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 12/13/2014

19:15—20:15
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is generously provided by other supporters of Keystone Symposia.


SUNDAY, JANUARY 18

 
Departure


*Session Chair †Invited, not yet responded.



Keystone Symposia thanks our Sponsors for generously supporting this meeting:

Astellas Pharma Inc. Bayer HealthCare Pharmaceuticals
Cell Signaling Technology, Inc. ImmunoGen, Inc.
Pfizer Inc. Takeda Pharmaceutical Company Limited

We gratefully acknowledge additional support for this conference from:

CEDARLANE Seahorse Bioscience, Inc.

We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



GlaxoSmithKline


Pfizer Global Research & Development


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

PLOS

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Amanda Deem, Assistant Director of Development, Email: AmandaD@keystonesymposia.org,
Phone:+1 970-262-2668

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676